1997
DOI: 10.1006/jcis.1996.4528
|View full text |Cite
|
Sign up to set email alerts
|

Kinetics of Human and Bovine Serum Albumin Adsorption at Silica–Titania Surfaces

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

14
162
1
2

Year Published

1999
1999
2014
2014

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 171 publications
(179 citation statements)
references
References 6 publications
14
162
1
2
Order By: Relevance
“…5). Adsorption on the uncoated Si 0.6 Ti 0.4 O 2 chip resulted in an essentially stable monolayer as observed previously [59]. Adsorption was increased by 92 ± 16% on the nanostructured titanate coating, while still resulting in an essentially stable monolayer (as inferred from the saturation of the adsorption with minor desorption after removal of the protein from the bulk solution).…”
Section: Protein Adsorption Experiments On the Tnt-coated And Uncoatesupporting
confidence: 77%
See 1 more Smart Citation
“…5). Adsorption on the uncoated Si 0.6 Ti 0.4 O 2 chip resulted in an essentially stable monolayer as observed previously [59]. Adsorption was increased by 92 ± 16% on the nanostructured titanate coating, while still resulting in an essentially stable monolayer (as inferred from the saturation of the adsorption with minor desorption after removal of the protein from the bulk solution).…”
Section: Protein Adsorption Experiments On the Tnt-coated And Uncoatesupporting
confidence: 77%
“…orders of magnitude greater than the size of the protein molecule and there is no hydromechanical force on the protein [59,60].…”
Section: Protein Adsorption Experiments On the Tnt-coated And Uncoatementioning
confidence: 99%
“…Therefore, BSA was substituted for HSA in our study. 12,13 Despite excellent biological properties in using albumin nanoparticles as drug delivery vehicles, further investigations on optimizing their ability to selectively target cancer cells and releasing chemotherapeutical agents in a controlled manner are much needed. To solve the problem of site-specific targeting, some researchers have attempted to enhance tissue specificity of albumin-based drug carriers by coupling them with targeting agents, such as follic acid 14 and transferrin.…”
Section: Introductionmentioning
confidence: 99%
“…2 This attribute has been demonstrated in the context of the adsorption of proteins at solid/liquid interfaces both theoretically 3 and experimentally. [4][5][6] Compact globular proteins ͑such as the abundant soluble proteins of the blood, e.g., albumin and transferrin͒ have been extensively investigated for decades, and many features of their behavior are understood; highly elongated fibrous proteins are known to follow more complicated multistructural trajectories ͑e.g., Refs. 7 and 8͒, and not all details of their adsorption and desorption processes have as yet been elucidated; even less is presently known about an even more complex class of objects, giant glycoproteins such as mucin, which have only recently become available in sufficiently high purity to permit truly quantitative experimentation with them.…”
mentioning
confidence: 99%